Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
08/2005
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649655A Crystallization system utilizing atomization
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/02/2005US6924391 Antiinflammatory agents; antitumor agent
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924251 herbicides.
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068432A1 Malononitrile compound as pesticides
07/28/2005US20050165234 novel compound having a 5-amino-4-oxopyrimidine backbone can be used as an intermediate for preparing an enzyme inhibitor
07/28/2005US20050165072 used as analgesics, antiepileptics agents, antidepressants, antiarrhythmia agents and for treatment of irritable bowel syndrome, Cnohn's disease, multiple sclerosis and bipolar disorders
07/28/2005US20050165026 cyclic diamine compound having potent ACAT inhibitory activity and high metabolic reshaving potent ACAT inhibitory activity and high metabolic resistance, and shows excellent suppressive effects on lipid deposition in artery; active on arterial ACAT and not small intestine or liver; reduced side effects
07/28/2005DE10360757A1 Verfahren zur Herstellung von Phenylenbisoxazolinen A process for preparing Phenylenbisoxazolinen
07/28/2005DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
07/27/2005EP1557410A2 Bacterial gyrase inhibitors and uses thereof
07/27/2005EP1556385A1 Heterocyclocarboxamide derivatives
07/27/2005EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases
07/27/2005EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
07/27/2005CN1646512A A semi-synthetic process for the preparation of N debenzoylpaclitaxel
07/27/2005CN1646504A Substituted benzoxazoles and analogues as estrogenic agents
07/27/2005CN1646476A Method for preparing combretastatins
07/27/2005CN1644578A AB type poly(p-phenyl) benzdioxan monomer and its preparation and use
07/27/2005CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them
07/27/2005CN1212117C Medicine composition for treating diabetes mellitus
07/26/2005CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives
07/21/2005WO2005066138A1 Substituted heterocyclic amides having a fungicidal effect
07/21/2005WO2005066120A2 Process for asymmetric synthesis of hydroxy-alkyl substituted azetidinone derivatives
07/21/2005WO2005065779A1 Calcitonin gene related peptide receptor antagonists
07/21/2005WO2005026137A3 Modulators of atp-binding cassette transporters
07/21/2005WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
07/21/2005US20050159598 Activators of human peroxisome proliferator activated receptors such as {2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methanol
07/21/2005US20050159596 Cyclic compounds and their use as complex ligands
07/21/2005US20050159466 Production method of isoxazolidinedione compound
07/21/2005US20050159452 Nociceptin analogs
07/21/2005US20050159427 N-acylsulfonamide apoptosis promoters
07/21/2005CA2549330A1 Calcitonin gene related peptide receptor antagonists
07/20/2005EP1555262A1 Methods of crystal precipitation
07/20/2005EP1555261A1 Valerolactone compounds and perfume composition
07/20/2005EP1555257A1 Process for producing aromatic nitrile compound
07/20/2005EP1324989A4 5-trityloxymethyl-oxazolidinones and process for the preparation thereof
07/20/2005EP1303514B1 Process for preparing azacycloalkanoylaminothiazoles
07/20/2005EP1286673B8 Ligands of integrin receptors
07/20/2005EP0901372B1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
07/20/2005EP0784430B1 Method for reducing unwanted cellular adhesions
07/20/2005CN1642927A Cyclic amides
07/20/2005CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
07/20/2005CN1642879A Process for producing biaryl compound
07/20/2005CN1642543A Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
07/20/2005CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them
07/19/2005US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury
07/19/2005US6919470 Aryl and heteroaryl sulfonates
07/19/2005US6919458 Preparation of terfenadine carboxylic acid metabolite and carebastine using a 1-(2-substituted isopropyl)-4-(cyclopropylcarbonyl)-benzene compound intermediate
07/19/2005US6919367 Substituted thioacetamides
07/19/2005US6919365 Also oxazolidinediones; excellant enzyme inhibitors of chymase and/or tryptase; antiallergens; antiinflammatory agents; vascular circulatory system disease; vision defects, antidiabetic and -arthritic agents; pancreatitis; hepatitis
07/19/2005US6919362 For use as hypoglycaemic and hypolipidaemic agents
07/19/2005US6919358 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
07/19/2005US6919329 Microorganisms; bactericides; human and veterinary medicine
07/19/2005US6919211 Solid support comprising amino acid sequences for sequencing, fingerprinting and mapping biological macromolecules; structure and function analysis
07/14/2005WO2005064006A1 OPTICALLY ACTIVE, HETEROAROMATIC β-HYDROXY ESTERS, PROCESSES FOR THEIR PREPARATION FROM β-KETO ESTERS AND PROCESSES FOR THE PREPARATION OF THESE β-KETO ESTERS
07/14/2005WO2005063742A2 Amidino compounds as cysteine protease inhibitors
07/14/2005WO2005063725A1 Phenylpropanoic acid derivatives
07/14/2005WO2005063724A1 1-(azolin-2-yl) amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes
07/14/2005WO2005063692A1 (hetero)cyclyl carboxanilides for controlling harmful fungi
07/14/2005WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR
07/14/2005WO2005040142B1 Novel keto-oxadiazole derivatives as cathepsin inhibitors
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154200 Method for producing cyclic carbamate ester
07/14/2005US20050154056 Inhibitors of HCV NS5B polymerase
07/14/2005US20050153973 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; enzyme inhibitors; diabetes
07/14/2005US20050153971 Halogenated biaryl heterocyclic compounds and methods of making and using the same
07/14/2005US20050153944 Oxazole derivatives of tetracyclines
07/14/2005US20050153363 Polymer arrays
07/14/2005US20050153362 Polymer arrays
07/14/2005DE10360369A1 Amide Amides
07/14/2005CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005CA2546981A1 Optically active, heteroaromatic .beta.-hydroxy esters, processes for their preparation from .beta.-keto esters and processes for the preparation of these .beta.-keto esters
07/13/2005EP1553091A1 Heteroaromatic pentacyclic compound and medicinal use thereof
07/13/2005EP1553090A1 Process for producing pyrimidine compound
07/13/2005EP1553085A1 Cyclic amine derivatives and their use as drugs
07/13/2005EP1552842A1 Bicyclic pyrimidine derivatives
07/13/2005EP1551814A1 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists
07/13/2005EP1551813A2 Chemical compounds
07/13/2005EP1551794A1 Ureido-substituted aniline compounds useful as serine protease inhibitors
07/13/2005EP1427711B1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
07/13/2005EP1178969B1 Gastrin and cholecystokinin receptor ligands
07/13/2005CN1639136A Oxazolidinone and/or isoxazoline as antibacterial agents
07/13/2005CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
07/13/2005CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636983A Substituted heterocyclic compounds
07/13/2005CN1636967A Noval compounds, their use and preparation
07/13/2005CN1636597A Compounds for the treatment of female sexual dysfunction
07/13/2005CN1210270C Novel use of phenylheteroalkylamine derivatives
07/13/2005CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
07/12/2005US6916761 Activity in water, easily recovered, and reusable; for example, a divinylbenzene-crosslinked polystyrene support with scandium bonded through a sulfonic acid group and esterified with trifluoromethanesulfonic acid
07/12/2005CA2143040C The use of benzazoles as uv absorbers, new benzazoles and a process for their preparation
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 210